Chongqing Lummy Pharmaceutical's holding subsidiary has obtained two medical device registration certificates.
LaiMei Pharmaceuticals (300006.SZ) announced that its holding subsidiary, Hainan LaiMei Medical Equipment Co., Ltd. (referred to as "LaiMei Medical Equipment"), has received two Medical Device Registration Certificates issued by the Hainan Provincial Drug Administration. The product names are: Medical Electronic Endoscope Image Processor and Electronic Bronchoscope.
Chongqing Lummy Pharmaceutical (300006.SZ) announced that its holding subsidiary, Hainan Lummy Medical Devices Co., Ltd. ("Lummy Medical Devices"), has received two Medical Device Registration Certificates issued by the Hainan Province Food and Drug Administration. The product names are: Medical Electronic Endoscope Image Processor, and Electronic Bronchoscope.
Related Articles
Ningbo Menovo Pharmaceutical (603538.SH) subsidiary obtains registration certificate for Nifedipine tablets.
VITASOY INT'L (00345) spent HKD 2.67 million on buying back 404,000 shares on December 10th.
Luenmei Quantum (600167.SH) subsidiary plans to participate in the establishment of Zhongcheng Lianhong private equity fund with 104 million yuan.
Ningbo Menovo Pharmaceutical (603538.SH) subsidiary obtains registration certificate for Nifedipine tablets.
VITASOY INT'L (00345) spent HKD 2.67 million on buying back 404,000 shares on December 10th.
Luenmei Quantum (600167.SH) subsidiary plans to participate in the establishment of Zhongcheng Lianhong private equity fund with 104 million yuan.
RECOMMEND
Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025
Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025
As The 2025 Central Economic Work Conference Approaches, What New Expectations Lie Ahead For Next Year’s Economic Agenda? Institutions Forecast Five Key Highlights
08/12/2025
